Ajanta Pharma Limited
Ajanta Pharma Limited (AJANTPHARM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
ajantapharma.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹3521.10
Market cap
43,433 Cr
Stock P/E
37.8
P/B
9.72
Dividend yield
0.8%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,028 Cr | 1,105 Cr | 1,054 Cr | 1,145 Cr | 1,187 Cr | 1,146 Cr | 1,170 Cr | 1,303 Cr | 1,354 Cr | 1,375 Cr | 1,422 Cr | 1,626 Cr |
| Operating expenses (approx.) | 738 Cr | 791 Cr | 776 Cr | 815 Cr | 875 Cr | 825 Cr | 873 Cr | 951 Cr | 1,026 Cr | 993 Cr | 1,088 Cr | 1,202 Cr |
| EBITDA | 291 Cr | 314 Cr | 278 Cr | 330 Cr | 311 Cr | 321 Cr | 297 Cr | 351 Cr | 328 Cr | 382 Cr | 333 Cr | 424 Cr |
| OPM % | 28.3% | 28.4% | 26.4% | 28.9% | 26.2% | 28.0% | 25.4% | 27.0% | 24.2% | 27.8% | 23.5% | 26.1% |
| Other income | 21 Cr | 14 Cr | 36 Cr | 26 Cr | 19 Cr | 30 Cr | 18 Cr | 26 Cr | 59 Cr | 25 Cr | 61 Cr | 71 Cr |
| Interest | 2 Cr | 2 Cr | 2 Cr | 0.73 Cr | 6 Cr | 8 Cr | 6 Cr | 5 Cr | 3 Cr | 5 Cr | 2 Cr | 3 Cr |
| Depreciation | 34 Cr | 34 Cr | 34 Cr | 34 Cr | 34 Cr | 36 Cr | 40 Cr | 41 Cr | 43 Cr | 44 Cr | 45 Cr | 45 Cr |
| Profit before tax | 276 Cr | 291 Cr | 278 Cr | 322 Cr | 290 Cr | 307 Cr | 269 Cr | 331 Cr | 341 Cr | 359 Cr | 347 Cr | 447 Cr |
| Tax % | 29.2% | 27.8% | 27.1% | 23.7% | 25.4% | 24.2% | 16.4% | 22.9% | 23.7% | 23.7% | 23.2% | 25.2% |
| Net profit | 195 Cr | 210 Cr | 203 Cr | 246 Cr | 216 Cr | 233 Cr | 225 Cr | 255 Cr | 260 Cr | 274 Cr | 267 Cr | 334 Cr |
| EPS (₹) | ₹15.51 | ₹16.68 | ₹16.10 | ₹19.54 | ₹17.27 | ₹18.60 | ₹18.00 | ₹20.44 | ₹20.83 | ₹21.91 | ₹21.35 | ₹26.75 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,055 Cr | 2,588 Cr | 2,890 Cr | 3,341 Cr | 3,743 Cr | 4,209 Cr | 4,648 Cr | 5,453 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,489 Cr | 1,905 Cr | 1,891 Cr | 2,412 Cr | 2,959 Cr | 3,037 Cr | 3,389 Cr | 4,058 Cr | Sign in for TTM |
| EBITDA | 566 Cr | 683 Cr | 999 Cr | 929 Cr | 783 Cr | 1,172 Cr | 1,260 Cr | 1,395 Cr | Sign in for TTM |
| OPM % | 27.6% | 26.4% | 34.6% | 27.8% | 20.9% | 27.8% | 27.1% | 25.6% | Sign in for TTM |
| Other income | 21 Cr | 92 Cr | 26 Cr | 116 Cr | 99 Cr | 85 Cr | 95 Cr | 172 Cr | Sign in for TTM |
| Interest | 1 Cr | 12 Cr | 8 Cr | 10 Cr | 6 Cr | 7 Cr | 21 Cr | 16 Cr | Sign in for TTM |
| Depreciation | 72 Cr | 96 Cr | 116 Cr | 125 Cr | 131 Cr | 135 Cr | 144 Cr | 173 Cr | Sign in for TTM |
| Profit before tax | 514 Cr | 664 Cr | 900 Cr | 909 Cr | 745 Cr | 1,114 Cr | 1,189 Cr | 1,378 Cr | Sign in for TTM |
| Tax % | 24.8% | 29.6% | 27.4% | 21.6% | 21.1% | 26.7% | 22.6% | 23.3% | Sign in for TTM |
| Net profit | 387 Cr | 468 Cr | 654 Cr | 713 Cr | 588 Cr | 816 Cr | 920 Cr | 1,056 Cr | Sign in for TTM |
| EPS (₹) | ₹43.97 | ₹53.60 | ₹75.09 | ₹82.45 | ₹45.89 | ₹64.82 | ₹73.56 | ₹84.53 | Sign in for TTM |
| Dividend payout % | — | — | — | 11.5% | 15.3% | 78.7% | 38.0% | 33.1% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 18 Cr | 18 Cr | 17 Cr | 17 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr |
| Reserves | 2,228 Cr | 2,581 Cr | 2,978 Cr | 3,247 Cr | 3,363 Cr | 3,542 Cr | 3,765 Cr | 4,502 Cr |
| Borrowings | 34 Cr | 44 Cr | 2 Cr | 2 Cr | 1 Cr | 1 Cr | 3 Cr | 212 Cr |
| Other liabilities | 417 Cr | 676 Cr | 781 Cr | 789 Cr | 1,290 Cr | 1,070 Cr | 1,222 Cr | 1,416 Cr |
| Total liabilities | 2,696 Cr | 3,319 Cr | 3,779 Cr | 4,056 Cr | 4,679 Cr | 4,638 Cr | 5,015 Cr | 6,155 Cr |
| Fixed assets (net) | 1,172 Cr | 1,360 Cr | 1,429 Cr | 1,424 Cr | 1,408 Cr | 1,384 Cr | 1,625 Cr | 1,726 Cr |
| CWIP | 261 Cr | 132 Cr | 108 Cr | 153 Cr | 209 Cr | 256 Cr | 176 Cr | 258 Cr |
| Investments | 78 Cr | 89 Cr | 185 Cr | 155 Cr | 535 Cr | 349 Cr | 464 Cr | 588 Cr |
| Loans & advances | 0 Cr | 9 Cr | 8 Cr | 6 Cr | 17 Cr | 34 Cr | 3 Cr | 2 Cr |
| Inventories | 436 Cr | 496 Cr | 766 Cr | 791 Cr | 816 Cr | 828 Cr | 904 Cr | 939 Cr |
| Trade receivables | 459 Cr | 775 Cr | 738 Cr | 1,020 Cr | 1,057 Cr | 1,247 Cr | 1,183 Cr | 1,854 Cr |
| Cash & bank | 95 Cr | 202 Cr | 178 Cr | 206 Cr | 330 Cr | 129 Cr | 175 Cr | 103 Cr |
| Other assets | 195 Cr | 255 Cr | 366 Cr | 299 Cr | 307 Cr | 411 Cr | 486 Cr | 685 Cr |
| Total assets | 2,696 Cr | 3,319 Cr | 3,779 Cr | 4,056 Cr | 4,679 Cr | 4,638 Cr | 5,015 Cr | 6,155 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 562 Cr | 792 Cr | 785 Cr | 1,157 Cr | 529 Cr |
| Cash from investing | — | — | — | -74 Cr | -560 Cr | 65 Cr | -377 Cr | -429 Cr |
| Cash from financing | — | — | — | -460 Cr | -108 Cr | -1,051 Cr | -733 Cr | -168 Cr |
| Net cash flow | — | — | — | 29 Cr | 123 Cr | -200 Cr | 46 Cr | -72 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 413 Cr | 617 Cr | 633 Cr | 839 Cr | 164 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 23.0% | 26.0% | 30.3% | 28.2% | 22.2% | 31.4% | 31.9% | 29.4% |
| ROE % | 17.1% | 18.0% | 21.8% | 0.0% | 0.0% | 22.9% | 24.3% | 23.3% |
| Debtor days | 81 | 109 | 93 | 111 | 103 | 108 | 93 | 124 |
| Inventory days | 405 | 323 | 395 | 369 | 338 | 322 | 389 | 373 |
| Days payable | 209 | 236 | 193 | 153 | 175 | 180 | 195 | 216 |
| Cash conversion cycle | 277 | 196 | 295 | 328 | 266 | 250 | 286 | 280 |
| Debt / equity | 0.02 | 0.02 | 0.0005 | 0.0006 | 0.0004 | 0.0004 | 0.0007 | 0.05 |
| Current ratio | 3.13 | 2.71 | 3.13 | 3.50 | 2.48 | 3.04 | 2.84 | 2.64 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -0.42 | -0.11 | -0.14 | 0.08 |
Compare with peers
Loading peers…